4//SEC Filing
Hoenlein Malcolm 4
Accession 0001415889-25-000425
CIK 0001429260other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:20 PM ET
Size
5.6 KB
Accession
0001415889-25-000425
Insider Transaction Report
Form 4
Hoenlein Malcolm
Director
Transactions
- Award
Common Stock, par value $0.001
2025-01-01+49,383→ 88,425 total
Footnotes (2)
- [F1]The Reporting Person was granted 49,383 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2026, 2027, and 2028, subject to continued service. The reporting person elected to defer 25% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
- [F2]Total holdings include 45,676 shares underlying deferred restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001294517
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:20 PM ET
- Size
- 5.6 KB